1. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
    Yash Gupta et al, 2023, Molecular Aspects of Medicine CrossRef
  2. Perspectives on Antiviral Drugs Development in the Treatment of COVID-19
    Aura Rusu et al, 2021, Acta Biologica Marisiensis CrossRef
  3. Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series
    Brandon Iturbe Esquivel et al, 2022, Monaldi Archives for Chest Disease CrossRef
  4. Repurposing of Chemotherapeutics to Combat COVID-19
    Sisir Nandi et al, 2022, Current Topics in Medicinal Chemistry CrossRef
  5. Strategies for drug repurposing against coronavirus targets
    Poppy O. Smith et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
  6. Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2
    Mahsa Ebrahimi et al, 2022, Catalysts CrossRef
  7. Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital
    Krista Yazareth Enríquez López et al, 2021, Cureus CrossRef
  8. Can anti-parasitic drugs help control COVID-19?
    Yasin Panahi et al, 2022, Future Virology CrossRef
  9. Fast one-pot microwave-assisted green synthesis of highly fluorescent plant-inspired S,N-self-doped carbon quantum dots as a sensitive probe for the antiviral drug nitazoxanide and hemoglobin
    Nermeen A. Qandeel et al, 2023, Analytica Chimica Acta CrossRef
  10. Post COVID-19 complications, adjunct therapy explored, and steroidal after effects
    Charu Sonkar et al, 2022, Canadian Journal of Chemistry CrossRef
  11. Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
    Simiso Sokhela et al, 2022, Journal of Antimicrobial Chemotherapy CrossRef
  12. NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects
    Mina T. Kelleni, 2022, Expert Review of Anti-infective Therapy CrossRef